| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.19B | 17.88B | 25.00B | 23.12B | 19.11B | 13.02B |
| Gross Profit | 1.41B | 3.71B | 5.55B | 4.90B | 4.43B | 2.98B |
| EBITDA | -1.32B | 943.00M | 2.88B | 2.41B | 2.11B | 960.89M |
| Net Income | -2.43B | 318.00M | 1.65B | 1.20B | 1.17B | 636.84M |
Balance Sheet | ||||||
| Total Assets | 21.78B | 25.66B | 28.98B | 28.29B | 19.76B | 13.83B |
| Cash, Cash Equivalents and Short-Term Investments | 2.38B | 2.17B | 3.32B | 4.81B | 4.73B | 3.33B |
| Total Debt | 5.82B | 7.56B | 6.70B | 9.33B | 5.36B | 4.78B |
| Total Liabilities | 11.89B | 13.19B | 16.56B | 19.95B | 12.45B | 7.69B |
| Stockholders Equity | 9.88B | 12.47B | 12.41B | 8.34B | 7.31B | 6.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.57B | -1.21B | -3.65B | 910.63M | -527.11M |
| Operating Cash Flow | 0.00 | -1.39B | -1.18B | -3.60B | 1.13B | 751.37M |
| Investing Cash Flow | 0.00 | 302.00M | 106.20M | -210.97M | -208.80M | -1.31B |
| Financing Cash Flow | 0.00 | 392.00M | -338.04M | 3.73B | 402.21M | 623.98M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥8.43B | 5.75 | ― | 3.07% | 8.75% | -27.34% | |
70 Outperform | ¥13.34B | 37.68 | ― | 3.47% | -14.79% | -41.15% | |
69 Neutral | ¥8.60B | -14.86 | ― | 3.26% | -54.42% | -69.81% | |
67 Neutral | ¥11.63B | 12.00 | 11.46% | 4.65% | 20.51% | 66.82% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥8.56B | -31.41 | ― | 2.61% | -25.28% | -434.79% | |
56 Neutral | ¥9.92B | 10.86 | ― | 1.86% | -7.54% | ― |